Gaithersburg, Maryland and SEOUL, Korea, – Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced the development of a new molecular assay for the quantification of twenty-onerespiratory viral pathogens associated with respiratory disease. QuantPlex RV-16 Assay will give physicians the specific information needed to guide patient treatment decisions, and […]
CARLSBAD, Calif. and SINGAPORE, — Life Technologies Corporation — (NASDAQ: LIFE) today announced that it has established a Global Instrument Center of Excellence in Singapore, to address strong customer demand around the world. The center will design and manufacture Life Technologies products, including next-generation sequencing and molecular diagnostic instruments for thousands of customers within the […]
SUNNYVALE, Calif., — Cepheid (Nasdaq: CPHD) today welcomed UNITAID’s announcement that it has approved funding of $30 million to scale up access to the “ground-breaking” Xpert MTB/RIF in high burden developing countries (HBDC). According to UNITAID, the funds will be used to roll out Xpert-based programs in around 20 countries, in addition to supporting a […]
SAN DIEGO, — Trovagene, Inc. (Nasdaq: TROV), (Nasdaq: TROVU),a developer of trans-renal molecular diagnostics, announced the full exercise of the over-allotment option granted to the underwriters to purchase 172,500 additional units, at a public offering price of $8.00 per unit, in connection with its previously announced underwritten public offering of 1,150,000 units, bringing total gross […]
OMAHA, Neb – Transgenomic, Inc. (OTC/BB: TBIO) today announced the appointment of John M. McAuliffe as Vice President of Business Development, Neurology, and Matthew W. Beer as Vice President of Business Development, Oncology. Mr. McAuliffe and Mr. Beer have strong backgrounds in business development for the life sciences and will lead the Company’s expansion efforts […]
Hubbard, Ohio — NanoLogix (OTC Markets:NNLX) announced today its R&D team in collaboration with University of Texas Health Science Center – Houston (UTHSC-Houston) researchers, are developing a multi-well, microplate reader variant of the company’s BioNanoFilter (BNF) diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results […]
Milford, Mass., – SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, has launched the first commercially available Anti-Dengue Mixed Titer Performance Panel. This new addition to the SeraCare line of infectious disease panels responds to growing demand for […]
Palo Alto, CA — Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of […]
Today’s announcement is the result of the collaboration between Genentech and Dako on a parallel US FDA approval process of Genentech’s cancer drug and Dako’s pharmDx™ assays. The Genentech cancer drug (pertuzumab) ? which has also received authorization from FDA ? will be marketed under the name Perjeta™. “The role of HER2 in diagnosis and […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) announced that the US Patent and Trademark Office has issued patent number US 8,137,919 entitled “Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including Cetuximab, Panitumumab and Erlotinib”. The patent was exclusively licensed to Transgenomic by the Montefiore Medical Center (Bronx, NY, US) and includes […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
